Technical Resources International, INC.
UEI FAA2LVENETH4 · MD · SAM.gov record ↗
$130.9M
FY2025 obligations
40
Contract awards
Jun 30, 2015
First action
Jul 1, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$130.9M
- General Services Administration$0
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N95025F00003 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. OTHER SUPPORT SERVICES. JULY 23, 2025 - JULY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00003 (TO3). | National Institutes Of Health | 541715 | $36K | Jul 22, 2025 | Jul 21, 2026 |
| 75N95025F00002 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2). | National Institutes Of Health | 541715 | $11K | Jul 22, 2025 | Jul 30, 2026 |
| 75N94025F00001 ↗ | NICHD:R&D:DATA COORDINATING CENTER FOR PREPARATION, TRAINING ACTIVITIES, ENROLLMENT AND DATA COLLECTION AND DATA ANALYSIS OF THE SPAN STUDY:NON-SEVERABLE | National Institutes Of Health | 541714 | $294K | Jul 31, 2025 | Jul 30, 2026 |
| 75N91022F00001 ↗ | TASK ORDER 1A -PROJECT KICKOFF MEETING AND TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU. | National Institutes Of Health | 541715 | $831K | Jul 31, 2022 | Jul 30, 2026 |
| 75N95025F00001 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1). | National Institutes Of Health | 541715 | $442K | May 14, 2025 | Nov 13, 2026 |
| 75N98026F00001 ↗ | TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2). | National Institutes Of Health | 541715 | $11K | Jun 4, 2026 | Mar 3, 2027 |
| 75N95024F00001 ↗ | CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947. | National Institutes Of Health | 541715 | $34K | Sep 9, 2024 | Mar 7, 2027 |
| 75N93023F00001 ↗ | REGULATORY OPERATIONS SUPPORT SERVICES | National Institutes Of Health | 541714 | $569K | Mar 30, 2023 | Mar 29, 2027 |
| 75N93024C00004 ↗ | CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) | National Institutes Of Health | 541715 | $47.3M | Mar 31, 2024 | Mar 30, 2027 |
| 75N93024F00001 ↗ | NIAID/DAIDS REGULATORY SUPPORT CENTER | National Institutes Of Health | 541714 | $36.7M | Apr 14, 2024 | Apr 13, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93024C00004 ↗ | CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) | National Institutes Of Health | 541715 | $47.3M | Mar 31, 2024 | Mar 30, 2027 |
| 75N93024F00001 ↗ | NIAID/DAIDS REGULATORY SUPPORT CENTER | National Institutes Of Health | 541714 | $36.7M | Apr 14, 2024 | Apr 13, 2027 |
| 75N91021C00013 ↗ | CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS. | National Institutes Of Health | 541715 | $19.4M | Jun 30, 2021 | Jun 29, 2027 |
| 75N91022C00014 ↗ | DRUG DEVELOPMENT SUPPORT FOR CTEP | National Institutes Of Health | 541715 | $16.2M | Jun 30, 2022 | Jun 29, 2027 |
| 75N93022C00010 ↗ | REGULATORY AFFAIRS SUPPORT | National Institutes Of Health | 541715 | $7.4M | Jun 30, 2022 | Jun 29, 2027 |
| 75N93025F00001 ↗ | DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES | National Institutes Of Health | 541714 | $5.8M | Apr 16, 2025 | Apr 15, 2027 |
| 75N91022F00001 ↗ | TASK ORDER 1A -PROJECT KICKOFF MEETING AND TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU. | National Institutes Of Health | 541715 | $831K | Jul 31, 2022 | Jul 30, 2026 |
| 75N93023F00001 ↗ | REGULATORY OPERATIONS SUPPORT SERVICES | National Institutes Of Health | 541714 | $569K | Mar 30, 2023 | Mar 29, 2027 |
| 75N95025F00001 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1). | National Institutes Of Health | 541715 | $442K | May 14, 2025 | Nov 13, 2026 |
| 75N93022F00001 ↗ | 'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)' | National Institutes Of Health | 541715 | $374K | Nov 30, 2021 | Aug 6, 2027 |
| 75N94025F00001 ↗ | NICHD:R&D:DATA COORDINATING CENTER FOR PREPARATION, TRAINING ACTIVITIES, ENROLLMENT AND DATA COLLECTION AND DATA ANALYSIS OF THE SPAN STUDY:NON-SEVERABLE | National Institutes Of Health | 541714 | $294K | Jul 31, 2025 | Jul 30, 2026 |
| 75N95025F00003 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. OTHER SUPPORT SERVICES. JULY 23, 2025 - JULY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00003 (TO3). | National Institutes Of Health | 541715 | $36K | Jul 22, 2025 | Jul 21, 2026 |
| 75N95024F00001 ↗ | CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947. | National Institutes Of Health | 541715 | $34K | Sep 9, 2024 | Mar 7, 2027 |
| 75N94019F00125 ↗ | NICHD:R&D:DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN):NON-SEVERABLE | National Institutes Of Health | 541714 | $11K | Sep 16, 2019 | Jul 30, 2025 |
| 75N98026F00001 ↗ | TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2). | National Institutes Of Health | 541715 | $11K | Jun 4, 2026 | Mar 3, 2027 |
| 75N95025F00002 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2). | National Institutes Of Health | 541715 | $11K | Jul 22, 2025 | Jul 30, 2026 |
| GS00F274CA ↗ | FEDERAL SUPPLY SCHEDULE CONTRACT | Federal Acquisition Service | 541620 | $0 | Sep 15, 2015 | — |
| 75N93024F00002 ↗ | DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES - CARRRP TASK AREA F | National Institutes Of Health | 541714 | $0 | Apr 16, 2024 | Apr 15, 2025 |
| 75N91024P00361 ↗ | CLINICAL TRIALS ACCRUAL QUALITY IMPROVEMENT PROGRAM (AQUIP) DATA AND INFORMATION TECHNOLOGY SUPPORT FOR THE US-LATIN AMERICAN-CARIBBEAN HIV/HPV PREVENTION CLINICAL TRIALS NETWORK (ULACNET) | National Institutes Of Health | 541990 | $0 | Jun 2, 2024 | Jun 1, 2025 |
| 75N95022C00032 ↗ | ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSIS, OPTION QUANTITY 3 REGULATORY SUPPORT, AND OPTION QUANTITY 4 GOVERNANCE LOGISTICS SUPPORT. | National Institutes Of Health | 541380 | $0 | Sep 21, 2022 | Sep 20, 2025 |
| 75A50122F33003 ↗ | BASE CONTRACT SERVICES TASK ORDER FOR CLINICAL STUDIES NETWORK (CSN) CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) YEAR 3 | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 27, 2022 | Sep 26, 2025 |
| 75N95020F00001 ↗ | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. TO3. NIDA REF. NO. N01DA-19-8947. PERIOD OF PERFORMANCE: 09/01/2020 TO 1/31/2025. | National Institutes Of Health | 541715 | $0 | Aug 31, 2020 | Oct 30, 2025 |
| 75N95023F00001 ↗ | PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 05/31/2025. NIDA REF. NO. N01DA-19-8947. CHANGE ORDER MODIFICATION. | National Institutes Of Health | 541715 | $0 | Aug 9, 2023 | Oct 30, 2025 |
| 75A50123F33004 ↗ | CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Aug 21, 2023 | Aug 20, 2028 |
| 75A50120D00018 ↗ | CLINICAL TRIALS PLANNING AND EXECUTION (TRI) | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 27, 2020 | — |